Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42K Buy
36
+35
+3,500% +$2.33K ﹤0.01% 1227
2026
Q1
$63 Hold
1
﹤0.01% 1099
2025
Q4
$66 Sell
1
-1
-50% -$65 ﹤0.01% 1141
2025
Q3
$135 Sell
2
-1,137
-100% -$90K ﹤0.01% 1078
2025
Q2
$96.9K Hold
1,139
0.05% 260
2025
Q1
$77.8K Buy
1,139
+1,039
+1,039% +$84.8K 0.03% 382
2024
Q4
$8.68K Buy
+100
New +$7.4K ﹤0.01% 809

Other funds holding DXCM

AmeriFlex Group's DXCM Position: Q2 2026 in Review

AmeriFlex Group increased its DexCom (DXCM) stake by 3,500% in Q2 2026, buying an estimated $2.33K and bringing the position to 36 shares worth $2.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1227.

AmeriFlex Group first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $96.9K in Q2 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • AmeriFlex Group held 36 shares of DexCom worth $2.42K as of Q2 2026.
  • AmeriFlex Group bought 35 DexCom shares in Q2 2026, an estimated $2.33K.
  • DexCom made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #1227 holding.
  • AmeriFlex Group first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's DexCom position peaked at $96.9K in Q2 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.